Sign In/ Sign Up
Take multiple biopsies in studies of personalised breast cancer treatments, study says
Nov 15, 2016
Clinicians should take multiple biopsies from patients in clinical trials of targeted breast cancer drugs to avoid missing key mutations with important implications for treatment, new research finds.
Genetic profiling of patients’ tumours using biopsies has become more common in recent years, helping to drive personalised therapy and ensure that patients receive the treatments most likely to be effective for them....
Take multiple biopsies in studies of personalised breast cancer treatments, study says - The Institute of Cancer Research, London
New research finds taking single biopsy can miss key genetic mutations that could influence drug susceptibility and resistance